On March 24th, Vice President Han Zheng met separately in Beijing with the CEO of Swire Group, Shi Minglun, and the CEO of Novartis AG, Wan Sihan, who came to China to attend the 2025 Annual Meeting of the China Development Forum. On March 24th, Vice President Han Zheng met with Shi Minglun, CEO of Swire Group, who came to China to attend the 2025 Annual Meeting of the China Development Forum. During the meeting with Shi Minglun, Han Zheng stated that the world is currently facing complex challenges and the international economic landscape is undergoing profound adjustments. China adheres to the correct direction of economic globalization, upholds the world trade rules system, and steadfastly promotes reform and opening up, injecting more stability and certainty into global economic development. Swire Group is a world-renowned multinational corporation that has achieved great development in both mainland China and Hong Kong. We hope that Taikoo Group will actively participate in the construction of the Guangdong Hong Kong Macao Greater Bay Area and the Hainan Free Trade Port, and make new contributions in supporting and consolidating Hong Kong's position as an international aviation hub. On March 24th, Vice President Han Zheng met with Wan Sihan, CEO of Novartis, who came to China to attend the 2025 Annual Meeting of the China Development Forum. During the meeting with Wan Sihan, Han Zheng stated that Novartis is a globally renowned innovative pharmaceutical company that has made significant contributions to human health. The Chinese government encourages and supports innovative drug research and development, strengthens intellectual property protection in accordance with the law, and provides a better innovation environment for foreign enterprises, including Novartis. I hope Novartis can seize the opportunity, fully leverage its own advantages, deepen and expand mutually beneficial cooperation, and achieve greater development in China. Shi Minglun and Wan Sihan highly praised the achievements of China's economic and social development in recent years, were optimistic about China's development prospects, and had confidence in investing in China. Both companies have expressed their commitment to long-term cooperation with China, and will continue to root themselves in China, deeply cultivate the Chinese market, expand investment in China, deepen cooperation with China in aviation, medicine and health, and promote mutually beneficial cooperation between the UK and China, as well as Switzerland and China, to achieve new results. (New Society)